GLP-1 RAs for type 2 diabetes significantly lower one-year mortality, especially in those also diagnosed with obstructive sleep apnea.

The FDA will aim to decide whether to approve medicines for vaping addiction, deafness, pancreatic cancer, IVF, mental health, and certain other diseases in 1 to 2 months, a change from the usual ...

Achieving sustained virological response after direct-acting antiviral therapy reduces liver-related events among those with decompensated HCV cirrhosis.

Nearly 700 medicines used in the US to treat common conditions contain at least 1 chemical sourced only in China.

The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...

Obeticholic acid added to ursodeoxycholic acid improved alkaline phosphatase and bilirubin levels among patients with PBC unresponsive to first-line therapy.

Prior authorizations affect 74% of people with cancer, of whom half reported that the health care teams fully handled it.

California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.

Cancer survivors who reported currently smoking or having previously smoked had 1.35 and 1.13 times increased rates of all-cause mortality, respectively, compared with patients who never smoked.

A diagnosis of distant breast, colorectal, or non-small cell cancer was less likely among individuals receiving housing assistance than among matched control individuals, compared to a localized ...